For IBD patients, the indoleamine 2,3-dioxygenase (IDO) pathway is enhanced, while the aryl hydrocarbon receptor (AhR) pathway is down-regulated (Agus et al.2018), which can also be found in high-fat diet mice (Laurans et al.2018). This evidence concerns the gene AHR and inflammatory bowel disease.